Black Rock Inc. Decibel Therapeutics, Inc. Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$2.41 - $4.81 $12,862 - $25,670	5,337 Added 0.3%	1,811,483 $6.97 Million
Q1 2023 May 12, 2023	BUY	$2.08 - $4.79 $2,159 - $4,972	1,038 Added 0.06%	1,806,146 $5.45 Million
Q4 2022 Feb 13, 2023	SELL	$1.86 - $3.54 $152,021 - $289,331	-81,732 Reduced 4.33%	1,805,108 $3.7 Million
Q3 2022 Nov 14, 2022	SELL	$3.82 - $5.61 $29,188 - $42,866	-7,641 Reduced 0.4%	1,886,840 $6.53 Million
Q2 2022 Aug 12, 2022	SELL	$1.85 - $4.21 $5,072 - $11,543	-2,742 Reduced 0.14%	1,894,481 $7.98 Million
Q1 2022 May 12, 2022	BUY	$2.83 - $5.03 $2.27 Million - $4.03 Million	801,010 Added 73.07%	1,897,223 $5.77 Million
Q4 2021 Feb 10, 2022	SELL	$4.57 - $8.58 $3.31 Million - $6.22 Million	-725,337 Reduced 39.82%	1,096,213 $5.1 Million
Q3 2021 Nov 09, 2021	SELL	$6.6 - $9.04 $18,216 - $24,950	-2,760 Reduced 0.15%	1,821,550 $14 Million
Q2 2021 Aug 11, 2021	BUY	$6.39 - $11.51 $11.7 Million - $21 Million	1,824,310 New	1,824,310 $15.7 Million

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.